Hippocratic AI, a California-based healthcare AI startup, has raised $141 million in a Series B funding round led by Kleiner Perkins, bringing its valuation to $1.64 billion and securing unicorn status. The company, which specializes in patient-facing AI agents for non-diagnostic healthcare tasks, aims to address global staffing shortages in the healthcare industry. Its AI agents, powered by the Polaris 2.0 architecture, assist with chronic care management, post-discharge follow-ups, and patient education, achieving over 200,000 patient interactions with a high satisfaction score of 8.7 out of 10. The funding will fuel international expansion into regions such as Europe, Southeast Asia, and Latin America and extend the company’s reach into new verticals like pharmaceutical clinical trial coordination and wellness coaching.
A key innovation is Hippocratic AI’s AI Agent App Store, which allows clinicians to design, test, and monetize task-specific AI agents. With over 300 agents across 25 specialties, the platform tackles challenges like postpartum mental health, diabetes care, and chronic disease management. To ensure safety, all agents undergo rigorous testing by licensed clinicians and a network of 6,000 nurses and 300 doctors before deployment. CEO Munjal Shah emphasized the company’s commitment to delivering AI agents that meet the safety standards of human clinicians. With significant backing from investors and rapid growth, Hippocratic AI is poised to transform healthcare by enhancing operational efficiency, addressing workforce shortages, and delivering scalable, patient-centered care solutions.